Hexarelin vs Sermorelin

Before anything else: the dataset lists Hexarelin and Sermorelin in each other's stacks. They are run together more often than they are chosen between, so if you came here for a winner, the first honest answer is that this may not be an either/or.

Both are classed here as growth hormone secretagogues, so this is a within-class choice: the mechanism is broadly shared and what separates them is kinetics, route, and how much has actually been tested.

The overlap is muscle growth and recovery and sleep. On this site's goal weighting — an editorial priority score, not a measure of effect size — Hexarelin rates 4/5 for muscle growth and Sermorelin rates 3/5.

Sermorelin sits one step firmer: approval from a regulator somewhere, though not a current FDA or EMA label — it was FDA approved as Geref, then withdrawn for commercial reasons. Hexarelin has controlled human trials behind it, without an approval — human GH-response data is real, but the response blunts within weeks. One tier is a real difference but not a decisive one; it should not on its own settle the choice.

Hexarelin is a subcutaneous injection and an intramuscular injection; Sermorelin is a subcutaneous injection. Both are injected, so route does not decide this one.

The kinetics are roughly 5× apart — 1 h for Hexarelin against 12 min for Sermorelin — and yet both are dosed once daily. That schedule is convention rather than clearance, which is worth knowing before you assume the two behave the same way between doses.

Committed time differs: Hexarelin runs 4 weeks, Sermorelin runs 12 weeks.

Sermorelin is rated beginner here and Hexarelin advanced. That rating is about how much can go wrong in handling, dosing and monitoring, not about how well either works.